Methods of Delivering Radioiododeoxyuridine for Glioma Treatment
Author Information
Author(s): Mairs R J, Wideman C L, Angerson W J, Whateley T L, Reza M S, Reeves J R, Robertson L M, Neshasteh-Riz A, Rampling R, Owens J, Allan D, Graham D I
Primary Institution: University of Glasgow
Hypothesis
Can tumor incorporation of [125I]IUdR be enhanced by protracted administration?
Conclusion
A sustained delivery system significantly improves the incorporation of [125I]IUdR in glioma treatment.
Supporting Evidence
- The study demonstrated nuclear uptake of [125I]IUdR in tumor cells while normal brain cells remained unaffected.
- Labelling indices were significantly higher with sustained release methods compared to single injection.
Takeaway
This study found that using a special pump to deliver medicine directly to brain tumors works better than just giving one shot.
Methodology
The study compared three methods of intracerebral delivery of [125I]IUdR in a rat glioma model.
Limitations
The study was conducted in a rat model, which may not fully represent human glioma treatment.
Participant Demographics
Wistar rats were used as the model for glioma.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website